Clinical Trial Update: ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ORSIRO stents with Xience PRIME stents using optical coherence tomography has completed in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Orsiro Stent
• Xience Prime Stent (everolimus-eluting stent)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED